BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10726061)

  • 1. Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent.
    Chu CK; Boudinot FD; Peek SF; Hong JH; Choi Y; Korba BE; Gerin JL; Cote PJ; Tennant BC; Cheng YC
    Antivir Ther; 1998; 3(Suppl 3):113-21. PubMed ID: 10726061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
    Peek SF; Cote PJ; Jacob JR; Toshkov IA; Hornbuckle WE; Baldwin BH; Wells FV; Chu CK; Gerin JL; Tennant BC; Korba BE
    Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replication.
    Aguesse-Germon S; Liu SH; Chevallier M; Pichoud C; Jamard C; Borel C; Chu CK; Trépo C; Cheng YC; Zoulim F
    Antimicrob Agents Chemother; 1998 Feb; 42(2):369-76. PubMed ID: 9527788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracil.
    Balakrishna Pai S; Liu SH; Zhu YL; Chu CK; Cheng YC
    Antimicrob Agents Chemother; 1996 Feb; 40(2):380-6. PubMed ID: 8834884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model.
    Seignères B; Martin P; Werle B; Schorr O; Jamard C; Rimsky L; Trépo C; Zoulim F
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1842-52. PubMed ID: 12760857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives for the treatment of hepatitis B virus infections.
    De Clercq E
    Int J Antimicrob Agents; 1999 Jul; 12(2):81-95. PubMed ID: 10418752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection.
    Menne S; Roneker CA; Tennant BC; Korba BE; Gerin JL; Cote PJ
    Intervirology; 2002; 45(4-6):237-50. PubMed ID: 12566706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique metabolism of a novel antiviral L-nucleoside analog, 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil: a substrate for both thymidine kinase and deoxycytidine kinase.
    Liu SH; Grove KL; Cheng YC
    Antimicrob Agents Chemother; 1998 Apr; 42(4):833-9. PubMed ID: 9559792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection.
    Menne S; Roneker CA; Korba BE; Gerin JL; Tennant BC; Cote PJ
    J Virol; 2002 Jun; 76(11):5305-14. PubMed ID: 11991959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks.
    Fourel I; Li J; Hantz O; Jacquet C; Fox JJ; Trépo C
    J Med Virol; 1992 Jun; 37(2):122-6. PubMed ID: 1629711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies.
    Zoulim F; Berthillon P; Guerhier FL; Seigneres B; Germon S; Pichoud C; Cheng YC; Trepo C
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S460-3. PubMed ID: 12534778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)uracil in woodchucks.
    Witcher JW; Boudinot FD; Baldwin BH; Ascenzi MA; Tennant BC; Du JF; Chu CK
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2184-7. PubMed ID: 9333045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection.
    Jacquard AC; Nassal M; Pichoud C; Ren S; Schultz U; Guerret S; Chevallier M; Werle B; Peyrol S; Jamard C; Rimsky LT; Trepo C; Zoulim F
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2683-92. PubMed ID: 15215126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure--activity relationships of 1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)pyrimidine nucleosides as anti-hepatitis B virus agents.
    Ma T; Pai SB; Zhu YL; Lin JS; Shanmuganathan K; Du J; Wang C; Kim H; Newton MG; Cheng YC; Chu CK
    J Med Chem; 1996 Jul; 39(14):2835-43. PubMed ID: 8709113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus.
    Chu CK; Ma T; Shanmuganathan K; Wang C; Xiang Y; Pai SB; Yao GQ; Sommadossi JP; Cheng YC
    Antimicrob Agents Chemother; 1995 Apr; 39(4):979-81. PubMed ID: 7786007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virus.
    Zhu Y; Cullen JM; Aldrich CE; Saputelli J; Miller D; Seeger C; Mason WS; Jilbert AR
    Virology; 2004 Sep; 327(1):26-40. PubMed ID: 15327895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks.
    Casey J; Cote PJ; Toshkov IA; Chu CK; Gerin JL; Hornbuckle WE; Tennant BC; Korba BE
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4396-9. PubMed ID: 16189132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the woodchuck hepatitis virus polymerase gene that confer resistance to lamivudine and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.
    Yamamoto T; Litwin S; Zhou T; Zhu Y; Condreay L; Furman P; Mason WS
    J Virol; 2002 Feb; 76(3):1213-23. PubMed ID: 11773397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anti-hepatitis B virus activity of 9-(2-deoxy-2-fluoro-beta-L-arabinofuranosyl) purine nucleosides.
    Ma T; Lin JS; Newton MG; Cheng YC; Chu CK
    J Med Chem; 1997 Aug; 40(17):2750-4. PubMed ID: 9276020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the unique mechanism of L-FMAU (clevudine) against hepatitis B virus: molecular dynamics studies.
    Chong Y; Chu CK
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3459-62. PubMed ID: 12419383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.